Fairvalue-Calculator Fairvalue-Calculator
EN DE

Nova Eye Medical Limited (ELXMF) Fair Value & Analysis

Healthcare · US · Market cap $4.1M

Price$0.0143
Fair Value$0.0142
Upside-0.4%
Quality95/100
Evidence: Low Range $0.0132 – $0.0153

Fair value as of: Jun 26, 2026

Analysis

Nova Eye Medical Limited (ELXMF) currently trades at $0.0143, while our model-based Fair Value estimate is $0.0142 — implying the stock looks roughly 0.4% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It also engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser; 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degeneration for the treatment of retinal disease. The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in patients glaucoma; iTrack Advance; and Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -9% Boston Scientific Corporation (B1SX34) -83% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Nova Eye Medical Limited (ELXMF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0142 versus a price of $0.0143 — about −0% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ELXMF?
Our 21-model fair value for Nova Eye Medical Limited is $0.0142 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0143.
What is the quality score of ELXMF?
Nova Eye Medical Limited has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.